TrialThe American journal of gastroenterology2015

A prospective randomized controlled study of long-term combination therapy using ursodeoxycholic acid and bezafibrate in patients with primary biliary cirrhosis and dyslipidemia.

Kenichi Hosonuma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.